Locate Bio Ltd (Locate), formerly RegenTec Ltd is a regenerative medicine development company that concentrates on drug delivery and tissue scaffold capabilities. The company develop its products for low back pain, and orthopedic biofilm infections. Locate provides clinical treatments throughout the body including orthopedic medicine, cell therapy, drug delivery, cell culture and veterinary medicine. The company promotes activities of receptor-binding moieties, locally applied drugs, and emergent biological and cell-based therapies. It serves pharmaceutical and biopharmaceutical companies. Locate is headquartered in Beeston, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Locate Bio Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Locate Bio Ltd Company Overview
- Locate Bio Ltd Company Snapshot
- Locate Bio Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Locate Bio Ltd - Pipeline Analysis Overview
- Locate Bio Ltd - Key Facts
- Locate Bio Ltd - Major Products and Services
- Locate Bio Ltd Pipeline Products by Development Stage
- Locate Bio Ltd Ongoing Clinical Trials by Trial Status
- Locate Bio Ltd Pipeline Products Overview
- Chondro3
- Chondro3 Product Overview
- CognitOss
- CognitOss Product Overview
- Ldgraft
- Ldgraft Product Overview
- Ldgraft Clinical Trial
- Locate Bio Ltd - Key Competitors
- Locate Bio Ltd - Key Employees
- Locate Bio Ltd - Locations And Subsidiaries
- Head Office
- Recent Developments
- Locate Bio Ltd, Recent Developments
- Nov 18, 2024: First Participant Treated in Groundbreaking LDGraft RESTORE Study for Spinal Fusion
- Apr 29, 2024: Locate Bio raises funding for LDGraft clinical study
- May 18, 2023: Locate Bio’s LDGraft granted FDA breakthrough device designation
- Feb 24, 2021: Locate Bio’s Chondro3 granted FDA Breakthrough Device Designation
- Jan 07, 2021: FDA grants breakthrough device designation to Locate Bio’s CognitOss
- Oct 16, 2018: Locate Therapeutics announces name change to Locate Bio and new investment from mercia technologies plc
- Jan 18, 2018: Locate Therapeutics Achieves ISO 13845 Certification
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Locate Bio Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Locate Bio Ltd Pipeline Products by Equipment Type
- Locate Bio Ltd Pipeline Products by Indication
- Locate Bio Ltd Ongoing Clinical Trials by Trial Status
- Locate Bio Ltd, Key Facts
- Locate Bio Ltd, Major Products and Services
- Locate Bio Ltd Number of Pipeline Products by Development Stage
- Locate Bio Ltd Pipeline Products Summary by Development Stage
- Locate Bio Ltd Ongoing Clinical Trials by Trial Status
- Locate Bio Ltd Ongoing Clinical Trials Summary
- Chondro3 - Product Status
- Chondro3 - Product Description
- CognitOss - Product Status
- CognitOss - Product Description
- Ldgraft - Product Status
- Ldgraft - Product Description
- Ldgraft - A Randomized Study of LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
- Ldgraft - A Study to Evaluate the Efficacy of LDGraft in Subjects Who Require Surgery for Chronic Lower Back Pain
- Locate Bio Ltd, Key Employees
- Glossary
- Locate Bio Ltd Pipeline Products by Equipment Type
- Locate Bio Ltd Pipeline Products by Development Stage
- Locate Bio Ltd Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- C. & L.E. Attenborough Ltd
- Progenitor Therapeutics Ltd
- Neotherix Ltd
